The New England journal of medicine, 2023-10, Vol.389 (15), p.1390-1401
- Holland, Thomas L.
- Cosgrove, Sara E.
- Doernberg, Sarah B.
- Jenkins, Timothy C.
- Turner, Nicholas A.
- Boucher, Helen W.
- Pavlov, Oleksander
- Titov, Ivan
- Kosulnykov, Serhii
- Atanasov, Boyko
- Poromanski, Ivan
- Makhviladze, Manana
- Anderzhanova, Anastasia
- Stryjewski, Martin E.
- Assadi Gehr, Maziar
- Engelhardt, Marc
- Hamed, Kamal
- Ionescu, Daniel
- Jones, Mark
- Saulay, Mikael
- Smart, Jennifer
- Seifert, Harald
- Fowler, Vance G.
2023
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Holland, Thomas L.
- Cosgrove, Sara E.
- Doernberg, Sarah B.
- Jenkins, Timothy C.
- Turner, Nicholas A.
- Boucher, Helen W.
- Pavlov, Oleksander
- Titov, Ivan
- Kosulnykov, Serhii
- Atanasov, Boyko
- Poromanski, Ivan
- Makhviladze, Manana
- Anderzhanova, Anastasia
- Stryjewski, Martin E.
- Assadi Gehr, Maziar
- Engelhardt, Marc
- Hamed, Kamal
- Ionescu, Daniel
- Jones, Mark
- Saulay, Mikael
- Smart, Jennifer
- Seifert, Harald
- Fowler, Vance G.
- Titel
- Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia
- Ist Teil von
- The New England journal of medicine, 2023-10, Vol.389 (15), p.1390-1401
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2023
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- In this trial involving 387 patients with Staphylococcus aureus bacteremia, ceftobiprole, a cephalosporin active against methicillin-sensitive and -resistant S. aureus , was noninferior to daptomycin.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa2300220Titel-ID: cdi_proquest_miscellaneous_2869615021
- Format
- –
- Schlagworte
- Abscesses, Administration, Intravenous, Adult, Adverse events, Anti-Bacterial Agents - administration & dosage, Anti-Bacterial Agents - adverse effects, Anti-Bacterial Agents - therapeutic use, Antibiotics, Aztreonam, Aztreonam - administration & dosage, Aztreonam - adverse effects, Aztreonam - therapeutic use, Bacteremia, Bacteremia - drug therapy, Bacteremia - microbiology, Bacterial Infections, Body weight, Cephalosporins - administration & dosage, Cephalosporins - adverse effects, Cephalosporins - therapeutic use, Daptomycin, Daptomycin - administration & dosage, Daptomycin - adverse effects, Daptomycin - therapeutic use, Data collection, Double-Blind Method, Drug resistance, Endocarditis, Enrollments, Humans, Hypothesis testing, Infectious Disease, Infectious Disease General, Laboratories, Methicillin, Methicillin-Resistant Staphylococcus aureus, Patients, Regulatory approval, Staphylococcal Infections - drug therapy, Staphylococcal Infections - microbiology, Staphylococcus aureus, Staphylococcus infections, Statistical analysis, Success, Treatment Outcome